Femoral Nerve Block for Analgesia After Anterior Cruciate Ligament Reconstruction

• Status: Completed
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Femoral nerve block using 0.25% bupivacaine or 0.5% bupivacaine provides a longer time for analgesia after Anterior Cruciate Ligament (ACL) reconstruction.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mahidol University
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• Patients scheduled for ACL reconstruction

• ASA physical status I-II

• Body weight > or = 50 kg.

Exclusion Criteria:

• Patients with redo ACL reconstruction

• Contraindication to neuraxial block

• allergy to local anesthetics, sulfa, NSAIDs, morphine, paracetamol

• Patients with communication problem